Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Zeybek, Ayça"'
Essai du traitement pré-clinique du carcinome hépatocellulaire sur la cirrhose dans le modèle de rat
Autor:
Zeybek, Ayça
Hepatocellular carcinoma (HCC) is the second most common cause of cancerrelated mortality worldwide. AKT pathway has been found activated in 50% of HCC cases, making it promising target. Therefore we assess efficacy of the allosteric AKT inhibitor or
Externí odkaz:
http://www.theses.fr/2016GREAV054/document
Publikováno v:
Chemical Biology & Drug Design. Jul2014, Vol. 84 Issue 1, p108-115. 8p.
Autor:
Zeybek, Ayça
Publikováno v:
Organic chemistry. İzmir Yüksek Teknoloji Enstitüsü (Izmir, Turquie), 2016. English. ⟨NNT : 2016GREAV054⟩
Hepatocellular carcinoma (HCC) is the second most common cause of cancerrelated mortality worldwide. AKT pathway has been found activated in 50% of HCC cases, making it promising target. Therefore we assess efficacy of the allosteric AKT inhibitor or
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::5a1ab5fdec70956f8647b860445b94d9
https://tel.archives-ouvertes.fr/tel-01685795
https://tel.archives-ouvertes.fr/tel-01685795
Autor:
Zeybek, Ayça
Kemoterapi birçok kanser türü için temel tedavi yöntemidir. Fakat maalesef, kanser hücrelerini etkilediği gibi sağlıklı hücreleri de etkilemekte ve onlara zarar vermektedir. Doksorubisin en yaygın kullanılan anti-kanser ilacı olmasına
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_____10208::4692db9f52284a87174dfc09724998fc
https://acikbilim.yok.gov.tr/handle/20.500.12812/640710
https://acikbilim.yok.gov.tr/handle/20.500.12812/640710
Publikováno v:
Chemical Biology & Drug Design. 84:108-115
WOS: 000337665900011
PubMed ID: 24524300
Magnetic albumin nanospheres that incorporate doxorubicin (M-DOX-BSA-NPs) were prepared previously by our research group to develop magnetically responsive drug carrier system. This nanocarrier was s
PubMed ID: 24524300
Magnetic albumin nanospheres that incorporate doxorubicin (M-DOX-BSA-NPs) were prepared previously by our research group to develop magnetically responsive drug carrier system. This nanocarrier was s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::26c2b440e0563d5685863b085b53e614
https://doi.org/10.1111/cbdd.12300
https://doi.org/10.1111/cbdd.12300